EMJ GOLD

GSK has ended its five-year neuroscience partnership with Alector after latozinemab and nivisnebart both failed.

The company has agreed to pay a subsidiary of Sino Biopharmaceutical $200 for an experimental COPD drug.

European Medical Group has been shortlisted at the Private Business Awards 2026, recognising its strong commercial growth and impact.

Haleon has partnered with Microsoft in a new five-year collaboration to scale AI capabilities across the business.

The PARTNERS trial has launched in the DRC as the country continues to battle an outbreak that has already led to more than 1,400 cases.

A new analysis is unequivocal in its criticism of the deal, while government officials have robustly defended its funding and value.

Discover the top pharma stories, from ovarian cancer and Ebola vaccines to the biotech M&A rebound.

Novo’s FDA-approved semaglutide injection and pill are now available through the Medicare GLP-1 Bridge.